Edgewise Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
23.80
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.36
|
-0.34
|
0.02
|
5.56%
|
|
2022-06-30
|
-0.32
|
-0.32
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.28
|
-0.30
|
-0.02
|
-7.14%
|
|
2021-12-31
|
-0.25
|
-0.26
|
-0.01
|
-4.00%
|
|
2021-09-30
|
-0.22
|
-0.26
|
-0.04
|
-18.18%
|
|
2021-06-30
|
-0.18
|
-0.21
|
-0.03
|
-16.67%
|
|
2021-03-31
|
-0.16
|
-4.37
|
-4.21
|
-2631.25%
|
|
2020-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.96
|
|
2021-12-31
|
-5.10
|
|
2020-12-31
|
0.00
|